FDA Approves New Drug to Prevent RSV in Babies and Toddlers
By DeECO |
Original Post For Immediate Release: July 17, 2023 Today, the U.S. Food and Drug Administration approved Beyfortus (nirsevimab-alip) for the ...
Read More FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
By DeECO |
Original Post For Immediate Release: June 20, 2023 Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) and Synjardy ...
Read More BearCare, Inc. Recalls Rechargeable Walnut Wearable Smart Thermometers for Risks of Serious Injury, including Burns During Use
By DeECO |
Original Post The FDA has identified this as a Class I recall, the most serious type of recall. Use of ...
Read More FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults
By DeECO |
Original Post For Immediate Release: May 25, 2023 Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid ...
Read More